Article Details

Ifinatamab Deruxtecan Continues to Demonstrate Durable Responses in Patients with ...

Retrieved on: 2023-09-11 08:00:52

Tags for this article:

Click the tags to see associated articles and topics

Ifinatamab Deruxtecan Continues to Demonstrate Durable Responses in Patients with .... View article details on HISWAI: https://pipelinereview.com/index.php/2023091184184/Antibodies/Ifinatamab-Deruxtecan-Continues-to-Demonstrate-Durable-Responses-in-Patients-with-Advanced-Small-Cell-Lung-Cancer-in-Early-Trial.html

Excerpt

Details: Category: Antibodies: Published on Monday, 11 September 2023 09:58 ... each ADC consists of a monoclonal antibody attached to a number of ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up